Nakayama Masaharu, Both Gerald W, Banizs Boglarka, Tsuruta Yuko, Yamamoto Seiji, Kawakami Yosuke, Douglas Joanne T, Tani Kenzaburo, Curiel David T, Glasgow Joel N
Division of Human Gene Therapy, Department of Medicine, University of Alabama at Birmingham, 901 19th Street South BMR2-572, Birmingham, AL 35294-2180, USA.
Virology. 2006 Jun 20;350(1):103-15. doi: 10.1016/j.virol.2006.01.037. Epub 2006 Mar 3.
Many clinically important tissues are refractory to adenovirus (Ad) infection due to negligible levels of the primary Ad5 receptor the coxsackie and adenovirus receptor CAR. Thus, development of novel CAR-independent Ad vectors should lead to therapeutic gain. Ovine atadenovirus type 7, the prototype member of genus Atadenovirus, efficiently transduces CAR-deficient human cells in vitro, and systemic administration of OAdV is not associated with liver sequestration in mice. The penton base of OAdV7 does not contain an RGD motif, implicating the long-shafted fiber molecule as a major structural dictate of OAdV tropism. We hypothesized that replacement of the Ad5 fiber with the OAdV7 fiber would result in an Ad5 vector with CAR-independent tropism in vitro and liver "detargeting" in vivo. An Ad5 vector displaying the OAdV7 fiber was constructed (Ad5Luc1-OvF) and displayed CAR-independent, enhanced transduction of CAR-deficient human cells. When administered systemically to C57BL/6 mice, Ad5Luc1-OvF reporter gene expression was reduced by 80% in the liver compared to Ad5 and exhibited 50-fold higher gene expression in the kidney than the control vector. To our knowledge, this is the first report of a fiber-pseudotyped Ad vector that simultaneously displays decreased liver uptake and a distinct organ tropism in vivo. This vector may have future utility in murine models of renal disease.
许多具有临床重要性的组织对腺病毒(Ad)感染具有抗性,这是因为主要的Ad5受体柯萨奇病毒和腺病毒受体(CAR)的水平极低。因此,开发新型的不依赖CAR的Ad载体应该会带来治疗上的益处。绵羊7型腺病毒(Ovine atadenovirus type 7)是Atadenovirus属的原型成员,它在体外能有效地转导缺乏CAR的人类细胞,并且向小鼠全身给药OAdV不会导致肝脏潴留。OAdV7的五聚体基座不包含RGD基序,这表明长杆状纤维分子是OAdV嗜性的主要结构决定因素。我们推测,用OAdV7纤维替换Ad5纤维会产生一种在体外具有不依赖CAR的嗜性且在体内肝脏“脱靶”的Ad5载体。构建了一种展示OAdV7纤维的Ad5载体(Ad5Luc1 - OvF),它对缺乏CAR的人类细胞表现出不依赖CAR的、增强的转导能力。当对C57BL/6小鼠进行全身给药时,与Ad5相比,Ad5Luc1 - OvF报告基因在肝脏中的表达降低了80%,并且在肾脏中的基因表达比对照载体高50倍。据我们所知,这是首次报道一种纤维假型化的Ad载体在体内同时表现出肝脏摄取减少和独特的器官嗜性。这种载体可能在肾脏疾病的小鼠模型中具有未来应用价值。